Comvita : 2016 Full Year Announcement

I N V E S T O R P R E S E N T A T I O N

A U G U S T 2 0 1 6

CHIEF EXECUTIVE OFFICER, SCOTT COULTER, 021 386 988

CHIEF FINANCIAL OFFICER, MARK SADD, 027 707 9698

Investor Presentation August 2016 1

I M P O R T A N T N O T I C E

This presentation is given on behalf of Comvita Limited. Information in this presentation:

• Should be read in conjunction with, and is subject to, Comvita's Annual Reports, Interim

  Reports and market releases on NZX;

• Is from audited financial statements for the 15 months ended 30 June 2016;

• May contain projections or forward-looking statements about Comvita. Such forward- looking statements are based on current expectations and involve risks and uncertainties. Comvita's actual results or performance may differ materially from these statements;

• Includes statements relating to past performance, which should not be regarded as a

  reliable indicator of future performance;

• Is for general information purposes only, and does not constitute investment advice;

• Is current at the date of this presentation, unless otherwise stated.

While all reasonable care has been taken in compiling this presentation, Comvita accepts no

responsibility for any errors or omissions.

All currency amounts are in NZ dollars unless otherwise stated.

Investor Presentation August 2016 2

Comvita announces 15 month result, delivering on guidance

Investor Presentation August 2016 3

K E Y A C H I E V E M E N T S

$231m

(15 Months)

CAGR

March 15-16

of 32%

S A L E S

G R O W T H

$18.5m

(15 Months)

Operating earnings of $17.1m in line with guidance

R E C O R D E A R N I N G S

Extended supply security via strategic alliances in both NZ and Australia

S U P P L Y S E C U R I T Y

Peer reviewed, published, clinical research studies on Olive Leaf Extract driving sales growth

C L I N I C A L S T U D I E S

Strategic investment in SeaDragon

E X T E N D E D

I N G R E D I E N T P L A T F O R M